Learning and development

Webinars

Short, informative sessions led by experts with firsthand experience.

Webinar

The road of radiopharmaceuticals towards clinical translation



May 12



16:00 CEST



30 min



Free

In this webinar, Maarten Brom (TRACER) & Theodoros Karampelas (BIOEMTECH) will answer the question:

“How do I avoid missing data on my CTA that causes delays?”

Missing data in your clinical trial application (CTA) can set you back by months.
In this webinar, you’ll learn step by step what is required to move a promising preclinical candidate into clinical trials.

The following aspects will be discussed:

  • Discovery stage
  • Preclinical in vivo studies
  • Required toxicity package
  • Regulatory package
  • Design an early-phase clinical trial
  • Study conduct and outcomes

Missed it?

Request a meeting

About the speakers

Maarten Brom (TRACER)
A seasoned scientist, specialised in chemistry and nuclear imaging techniques. Maarten is VP Technology Assessment at TRACER and a senior scientist with a focus on the development and characterization of radiolabeled and fluorescent tracers. He had various roles as a scientist at the Radboud University Medical Center in Nijmegen, The Netherlands, where his research in in vivo imaging techniques had a strong translational character.

Theodoros Karampelas (BIOEMTECH)
Biotechnologist with a PhD in Pharmacology, Thodoris has been active in drug discovery since 2009, with a strong focus on targeted anticancer agents. He has extensive experience across preclinical drug development, both in vitro and in vivo, as well as in bioanalysis and quality systems based on ISO 17025 and GLP. Since joining BIOEMTECH in 2021, he has served as CSO, leading the scientific foundation of the company’s current and future preclinical services.